Research has utilized ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) to explore the intricate relationship between sodium intake and cardiometabolic risk by identifying metabolites. Recent findings from a study conducted on the Swedish CardioPulmonary bioImage Study (SCAPIS) cohort revealed significant insights into the correlation between sodium intake and plasma metabolite profiles. This comprehensive research, involving […]
Category: Lipid Metabolism
Innovative ANGPTL3-Targeting Therapies for High Cholesterol
Exciting developments in the biotech industry are paving the way for new treatments targeting high cholesterol. Recent studies presented at the American College of Cardiology Scientific Session have shown promising results for ANGPTL3-targeting drugs developed by Eli Lilly and Jiangsu Hengrui Pharmaceuticals. Eli Lilly’s solbinsiran, a small interfering RNA therapy, demonstrated significant reductions in apolipoprotein […]